Investment Thesis
Hikma Ventures invests in healthcare and life sciences businesses where Hikma’s expertise and global presence can support growth; it is stage-agnostic and prefers Series A and later.
Stage Focus
Series A and beyond (stage-agnostic)
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Drug Delivery, Digital Therapeutics, Clinical Trial Innovation, Respiratory, CNS, Oncology, Autoimmune Diseases, Chronic Diseases (Type II Diabetes, hypertension), Overdose and Abuse solutions
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
N/A
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (9)
A
Ahmad Fayyad
Principal
A
Ali Al-Husry
Non-Executive Director
B
Bassam Kanaan
EVP, Corporate Development and M&A
C
Cynthia Flowers
Independent Non-Executive Director
D
Deneen Vojta
Independent Non-Executive Director
H
Haya Khoury
Analyst
L
Lana Ghanem
Managing Director
M
Mazen Darwazah
Executive Vice Chairman, President of MENA
S
Salma Al-Zu'bi
Principal
